Jennifer Mammen

Dr. Jennifer Mammen

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2023 in Journal of Parkinson’s Disease
Verified
Journal Article
Open access
PDF file
JMJennifer Mammen
Jennifer Mammen
RSRebecca M. Speck
Rebecca M. Speck
GSGlenn T. Stebbins
Glenn T. Stebbins
MMMartijn L.T.M. Müller
Martijn L.T.M. Müller
PYPhillip T. Yang
Phillip T. Yang
JAJamie L. Adams
Jamie L. Adams
Background: Patient perspectives on meaningful symptoms and impacts in early Parkinson’s disease (PD) are lacking and are urgently needed to clarify priority areas for monitoring, management, and new therapies. Objective: To examine experiences of people with early-stage PD, systematically describe meaningful symptoms and impacts, and determine which are most bothersome or important. Methods: Forty adults with early PD who participated in a study evaluating smartwatch and smartphone digital measures (WATCH-PD study) completed online interviews with symptom mapping to hierarchically delineate symptoms and impacts of disease from “Most bothersome” to “Not present,” and to identify which of these were viewed as most important and why. Individual symptom maps were coded for types, frequencies, and bothersomeness of symptoms and their impacts, with thematic analysis of narratives to explore perceptions. Results: The three most bothersome and important symptoms were tremor, fine motor difficulties, and slow movements. Symptoms had the greatest impact on sleep, job functioning, exercise, communication, relationships, and self-concept— commonly expressed as a sense of being limited by PD. Thematically, most bothersome symptoms were those that were personally limiting with broadest negative impact on well-being and activities. However, symptoms could be important to patients even when not present or limiting (e.g., speech, cognition). Conclusion: Meaningful symptoms of early PD can include symptoms that are present or anticipated future symptoms that are important to the individual. Systematic assessment of meaningful symptoms should aim to assess the extent to which symptoms are personally important, present, bothersome, and limiting

17 April 2023 in Journal of Parkinson’s Disease
Verified
Journal Article
Open access
PDF file
JMJennifer Mammen
Jennifer Mammen
RSRebecca M. Speck
Rebecca M. Speck
GSGlenn M. Stebbins
Glenn M. Stebbins
MMMartijn L.T.M. Müller
Martijn L.T.M. Müller
PYPhillip T. Yang
Phillip T. Yang
JAJamie L. Adams
Jamie L. Adams
Background: Adoption of new digital measures for clinical trials and practice has been hindered by lack of actionable qualitative data demonstrating relevance of these metrics to people with Parkinson’s disease. Objective: This study evaluated of relevance of WATCH-PD digital measures to monitoring meaningful symptoms and impacts of early Parkinson’s disease from the patient perspective. Methods: Participants with early Parkinson’s disease (N = 40) completed surveys and 1:1 online-interviews. Interviews combined: 1) symptom mapping to delineate meaningful symptoms/impacts of disease, 2) cognitive interviewing to assess content validity of digital measures, and 3) mapping of digital measures back to personal symptoms to assess relevance from the patient perspective. Content analysis and descriptive techniques were used to analyze data. Results: Participants perceived mapping as deeply engaging, with 39/40 reporting improved ability to communicate important symptoms and relevance of measures. Most measures (9/10) were rated relevant by both cognitive interviewing (70–92.5%) and mapping (80–100%). Two measures related to actively bothersome symptoms for more than 80% of participants ( Tremor, Shape rotation). Tasks were generally deemed relevant if they met three participant context criteria: 1) understanding what the task measured, 2) believing it targeted an important symptom of PD (past, present, or future), and 3) believing the task was a good test of that important symptom. Participants did not require that a task relate to active symptoms or “real” life to be relevant. Conclusion: Digital measures of tremor and hand dexterity were rated most relevant in early PD. Use of mapping enabled precise quantification of qualitative data for more rigorous evaluation of new measures.

16 October 2020 in Journal of Asthma
Verified
Journal Article
Open access
JMJennifer Mammen
Jennifer Mammen
JSJudith D. Schoonmaker
Judith D. Schoonmaker
JJJames Java
James Java
JHJill Halterman
Jill Halterman
MBMarc N. Berliant
Marc N. Berliant
Kimberly ArcoleoKimberly Arcoleo
Kimberly Arcoleo
The majority of adults with persistent asthma have chronically uncontrolled disease and interventions to improve outcomes are needed. We evaluated the efficacy, feasibility, and acceptability of a ...

3 April 2025 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
JMJennifer Mammen
Jennifer Mammen
JAJamie L. Adams
Jamie L. Adams
RMRikki Mangrum
Rikki Mangrum
YXYuge Xiao
Yuge Xiao
WBWilliam Barbosa
William Barbosa
DSDiane Stephenson
Diane Stephenson
A comprehensive, patient-centered conceptual model of early Parkinson’s is lacking and is greatly needed. A systematic review and meta-synthesis of qualitative and quantitative research was conducted by a multi-stakeholder taskforce using JBI Mixed Methods Review criteria and GRADE-CERQual standards for assessment of evidence. Over 340 symptoms and impacts were identified across ten symptom domains (Movement, Cognitive, Psychiatric, Sleep, Sensory, Speech, Digestive, Urinary, Sexual, Autonomic) and two impact domains (Physical and Psychosocial functioning). A wide range of motor and non-motor symptoms were present in early disease, with strongest support for tremor, dexterity, gait, stiffness, slow movements, cognitive, mood, and sleep alterations, urinary dysfunction, constipation, pain, and fatigue. These affected mobility, self-concept, coping, effort of living, interactions and important activities, with evidence of many understudied concepts. This model offers the most comprehensive catalogue of symptoms and impacts in Parkinson’s to date and will support clinical practice and endpoint selection for therapeutic trials.

15 November 2018 in Research in Nursing & Health
Verified
Journal Article
Closed access
PDF file
JMJennifer Mammen
Jennifer Mammen
CMCorey R. Mammen
Corey R. Mammen

11 September 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JMJennifer Mammen
Jennifer Mammen
MTMirinda Tyo
Mirinda Tyo
JCJoyce Cadorette
Joyce Cadorette
JAJamie L. Adams
Jamie L. Adams
YXYuge Xiao
Yuge Xiao
CBClaire Bale
Claire Bale
Understanding what matters to people with Parkinson’s and their family is essential to derive relevant clinical outcome measures and guide clinical care. The purpose of this study was to explore what is important to people with Parkinson’s disease vs. family over time. A qualitative content-analysis of online survey data collected by Parkinson’s UK was conducted to identify types and frequencies of important symptoms and impacts of Parkinson’s for people with the disease vs. family of people with Parkinson’s. Independent T-tests were used to identify significance of between group differences for patients vs. family at < 2, 2–5, 6–10, 11–20, > 20-year durations. ANOVA was used to assess for within group differences by disease duration. We found that symptom priority changed significantly over time with longer disease duration. Tremor was reported less often later on, whereas mobility, dyskinesias, gait and speech/communication symptoms gained priority. In general, patients identified movement-related symptoms (e.g., walking, bradykinesia) as the most bothersome at all durations while family more strongly prioritized the physical and psychosocial impacts of disease (e.g., mobility, safety, interpersonal interactions, independence, and family impact). We conclude that important differences exist between family and patient perspectives of what matters and change over time with longer duration of disease.